These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 19264253

  • 1. Vasodilator therapy in cardiac failure what was new is old.
    O'Rourke MF, Nichols WW.
    J Am Coll Cardiol; 2009 Mar 10; 53(10):898; discussion 898-99. PubMed ID: 19264253
    [No Abstract] [Full Text] [Related]

  • 2. Vasodilator therapy for decompensated heart failure.
    Yancy CW.
    J Am Coll Cardiol; 2008 Jul 15; 52(3):208-10. PubMed ID: 18617069
    [No Abstract] [Full Text] [Related]

  • 3. [Vasodilator therapy of heart failure].
    Mathey D.
    Dtsch Med Wochenschr; 1979 Apr 20; 104(16):563-4. PubMed ID: 108068
    [No Abstract] [Full Text] [Related]

  • 4. New approaches in the management of heart failure.
    Mason DT.
    Adv Myocardiol; 1980 Apr 20; 1():453-68. PubMed ID: 6994186
    [No Abstract] [Full Text] [Related]

  • 5. Vasodilator therapy of cardiac failure: (first of two parts).
    Cohn JN, Franciosa JA.
    N Engl J Med; 1977 Jul 07; 297(1):27-31. PubMed ID: 405585
    [No Abstract] [Full Text] [Related]

  • 6. Heart failure in aortic stenosis - improving diagnosis and treatment.
    Zile MR, Gaasch WH.
    N Engl J Med; 2003 May 01; 348(18):1735-6. PubMed ID: 12724478
    [No Abstract] [Full Text] [Related]

  • 7. [Vasodilator therapy in cardiac insufficiency].
    Vincent JL, Goldstein J, Leeman M, Lignian H.
    Rev Med Brux; 1984 Nov 01; 5(9):589-92. PubMed ID: 6522891
    [No Abstract] [Full Text] [Related]

  • 8. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WH.
    J Am Coll Cardiol; 2008 Jul 15; 52(3):200-7. PubMed ID: 18617068
    [Abstract] [Full Text] [Related]

  • 9. Nitroprusside in decompensated heart failure: what should a clinician really know?
    Opasich C, Cioffi G, Gualco A.
    Curr Heart Fail Rep; 2009 Sep 15; 6(3):182-90. PubMed ID: 19723460
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of cardiac insufficiency with systemic vasodilator agents].
    García Puig J, Gil Aguado A, Arnalich F, Gaspar G, Anciones B, Vázquez JJ.
    Med Clin (Barc); 1980 Nov 25; 75(9):398-403. PubMed ID: 7464335
    [No Abstract] [Full Text] [Related]

  • 11. Milrinone: a positive inotropic vasodilator.
    Colucci WS, Jaski BE, Fifer MA, Wright RF, Braunwald E.
    Trans Assoc Am Physicians; 1984 Nov 25; 97():124-33. PubMed ID: 6535335
    [No Abstract] [Full Text] [Related]

  • 12. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC, Robinson PH.
    Prim Care; 1981 Sep 25; 8(3):467-81. PubMed ID: 6796986
    [No Abstract] [Full Text] [Related]

  • 13. [Acute heart failure and vasodilator therapy].
    Sekiguchi M, Hiroe M, Osamura Y, Take M.
    Nihon Rinsho; 1978 Nov 10; 36(11):3554-64. PubMed ID: 104067
    [No Abstract] [Full Text] [Related]

  • 14. Principles of vasodilator therapy for left ventricular congestive heart failure.
    Giles TD.
    Heart Lung; 1980 Nov 10; 9(2):271-6. PubMed ID: 6898605
    [No Abstract] [Full Text] [Related]

  • 15. Vasodilators in the management of acute heart failure.
    Elkayam U, Janmohamed M, Habib M, Hatamizadeh P.
    Crit Care Med; 2008 Jan 10; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [Abstract] [Full Text] [Related]

  • 16. Concepts of peripheral circulatory control: implications for vasodilator therapy in heart failure.
    Rubin SA, Swan HJ.
    Cardiovasc Clin; 1984 Jan 10; 14(3):19-29. PubMed ID: 6144389
    [No Abstract] [Full Text] [Related]

  • 17. [Hemodynamic effects of vasodilators in aged patients with heart failure].
    Chen RX, Lu QQ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Sep 10; 13(4):249-51, 317. PubMed ID: 3836878
    [No Abstract] [Full Text] [Related]

  • 18. Aortic input impedance in heart failure: comparison with normal subjects and its changes during vasodilator therapy.
    Merillon JP, Fontenier G, Lerallut JF, Jaffrin MY, Chastre J, Assayag P, Motte G, Gourgon R.
    Eur Heart J; 1984 Jun 10; 5(6):447-55. PubMed ID: 6745286
    [Abstract] [Full Text] [Related]

  • 19. Preload and afterload without anguish: a simplified framework.
    Mandell HN, Deglin SM.
    Postgrad Med; 1982 May 10; 71(5):105-12. PubMed ID: 6803231
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.